Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 15, 2026Reported sale · Form 4Matthew Rabinowitz, EXECUTIVE CHAIRMAN · $111.1KOpen the filing ↗
- Oct 15, 2026Reported sale · Form 4Matthew Rabinowitz, EXECUTIVE CHAIRMAN · $278.3KOpen the filing ↗
- Oct 15, 2026Reported sale · Form 4Matthew Rabinowitz, EXECUTIVE CHAIRMAN · $234.1KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,70612 flagged findings
Reported transactions (Form 4)80since Apr 22, 2025 · and 13 other holdings
Corporate events (8-K)30since Apr 18, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-08share offering or dilution eventrecentOpen filing ↗“…commencing in February 2024, and can be converted to MyOme’s common stock upon the occurrence of MyOme’s initial public offering…”
+1 more passage from the same document
- “…upon the achievement of certain product commercialization milestones, the Company is eligible to receive an additional…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,706)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 16, 26Form 4 ↗Insider transaction new
- Oct 15, 26Form 144 ↗Notice of proposed sale new
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Oct 1, 26Form 144 ↗Notice of proposed sale
- Oct 1, 26Form 144 ↗Notice of proposed sale
- Sep 25, 26Form 4 ↗Insider transaction
- Sep 23, 26Form 144 ↗Notice of proposed sale
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Sep 15, 26Form 144 ↗Notice of proposed sale
- Sep 11, 26Form 144 ↗Notice of proposed sale
Notice of proposed sale · 3 Form 144 filingsshow all 3hide
- Sep 2, 26Form 144 ↗Notice of proposed sale
- Sep 1, 26Form 144 ↗Notice of proposed sale
- Sep 1, 26Form 144 ↗Notice of proposed sale
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · T. Rowe Price Associates, Inc. · 6.3% · event on Jun 30, 26 · amendment
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Aug 7, 26Form 144 ↗Notice of proposed sale
- Aug 7, 26Form 144 ↗Notice of proposed sale
1,706 filings on record, the oldest from Jul 1, 15.
Listing the 25 most recent filings of the 1,706 on record.
2624
5 senior executive changes2026show all 5hide
- Jul 6, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 16, 26A senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
- Jun 16, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 5, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 1, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Dec 5, 25Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
4 senior executive changes2024 – 2025show all 4hide
- Jun 18, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 12, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Dec 6, 24A senior executive left or was appointed8-K 5.02 ↗
- Jun 18, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Sep 7, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 21, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 23, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 16, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
3 senior executive changes2022show all 3hide
- Aug 15, 22A senior executive left or was appointed8-K 5.02 ↗
- Apr 15, 22A senior executive left or was appointed8-K 5.02 ↗
- Mar 14, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 22, 21Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 10, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 23, 20A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
3 material agreements entered2020show all 3hide
- Sep 11, 20Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 12, 20Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Apr 16, 20Entered a material agreement+4 more in the same filing8-K 1.01 ↗
5 older filings not shown · The record reaches back to Oct 30, 15.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- JPMORGAN CHASE & CO.9.1%Dec 31, 25SCHEDULE 13G/A ↗2 earlier filings
- T. Rowe Price Associates, Inc.6.3%Jun 30, 26SCHEDULE 13G/A ↗4 earlier filings
- BlackRock, Inc.5.6%Mar 31, 25SCHEDULE 13G/A ↗
- Vanguard Capital Management5.1%Mar 31, 26SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Oct 15, MATTHEW RABINOWITZ filed notice of intent to sell up to $19.7M. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $20.1M across 19 trades on Oct 15, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+9 more recent notices · 9 with a later sale
- Oct 15, 26Sell$111KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$278KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$234KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$117KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$315KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$118KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$753KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$437KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$239KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$317KMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$1.1MMatthew RabinowitzEXECUTIVE CHAIRMAN↗
- Oct 15, 26Sell$2.4MMatthew RabinowitzEXECUTIVE CHAIRMAN↗
There are 26 more transactions in this stretch.
Stock compensation, tax and giftsshow the 2 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 1,647 transactions and goes back to Sep 23, 22.
Its sector and its market
Natera, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Natera, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Natera, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,706 documents on file, from Jul 1, 2015 to Oct 16, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.